Order book
Specific profit guidance for FY11 has not been provided. However, management expects
contracts awarded in the latter part of FY10 to contribute to significant growth in FY11.
Furthermore, Envirochem, acquired in May 2010 for A$3m, is tracking well and should contribute
at least A$1m to EBIT in FY11.
Our estimate of TOX?s contract profile is summarised below. Based on our forecasts, additional
revenue from contracts awarded during FY10 and FY11 will represent approximately A$25.5m of
the A$30m increase in revenue we have forecast for FY11. There are plans to upgrade or relocate
the incinerator from Port Hedland to Karratha, however, this could be 12-18 months away.
Changes to our forecasts
Changes to our forecasts are summarised in the table below. Key changes relate to higher capex
requirement and associated depreciation, higher corporate overhead and A$1.4m for provisions
for doubtful debts. Acquisitions and potential from QLD flood clean up are not included in our
forecasts.
Valuation, target price and risks
TOX is on the cusp of significant growth from FY11 and FY12. We apply a PE valuation multiple
to value TOX at A$2.44 per share. We apply a PE multiple of 13.75x to our revised FY12 EPS
(basic) forecasts, which is a 20% premium to the small industrial index of 11.5x but below its
larger competitor, Transpacfic Industries (TPI), which trades on 15.4x FY12. We believe the
premium to the small industrials is justified given TOX?s oligopolistic position in particular market
segments, solid balance sheet, above-average margins and significantly higher EPS growth
profile (average 42% pa for FY11-12F vs small industrials? 17.5%pa).
Growth forecasts for FY11 are underpinned by a ramp-up of contracts awarded in FY10 and
FY11, including Gorgon, Rio Tinto, Murrin Murrin, Boral Cement and Apach. The company
continues to tender for more contracts and is confident of further awards. The tender book is in
the order of $70m, and near-term prospects include Port Perie and Wheatstone.
We continue to like TOX?s long-term outlook for its leverage to the resources and oil and gas
sectors, strong balance sheet and a strategic market position. However, as the shares are now
trading within 10% of our revised price target of A$2.39, we move to a Hold rating.
Upside risks include new contracts, acquisitions, longer-than-expected impact of the flood clean
up and faster-than-expected recovery in the manufacturing sector or corporate activity.
Key downside risks include acquisition integration, losses on contracts, regulatory change, a
slowdown in construction activity and a slower-than-expected recovery in manufacturing and
operational risks.
- Forums
- ASX - By Stock
- TOX
- rbs report
rbs report, page-2
Featured News
Add TOX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online